HI SB1213 | 2023 | Regular Session
Note: Carry Foward to future SB1213
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 25 2023 - 25% progression, died in committee
Action: 2023-01-27 - Referred to HHS/EDU, JDC.
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 25 2023 - 25% progression, died in committee
Action: 2023-01-27 - Referred to HHS/EDU, JDC.
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Requires all private schools to develop and implement comprehensive action plans for the management of anaphylaxis in their respective schools, including administration of auto-injectable epinephrine. Establishes certain immunity from liability for designated private school employees and agents who administer auto-injectable epinephrine during emergencies.
Title
Relating To Education.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-01-27 | Senate | Referred to HHS/EDU, JDC. |
| 2023-01-25 | Senate | Passed First Reading. |
| 2023-01-25 | Senate | Introduced. |
Same As/Similar To
SB1213 (Carry Over) 2023-01-27 - Referred to HHS/EDU, JDC.
HB183 (Same As) 2023-01-25 - Referred to HLT, EDN, JHA, referral sheet 1
HB183 (Same As) 2023-01-25 - Referred to HLT, EDN, JHA, referral sheet 1
Subjects
Anaphylaxis Management
Auto-injectable Epinephrine
Comprehensive Action Plans
Designated School Employee and Agents
Immunity from Liability
Private Schools
Auto-injectable Epinephrine
Comprehensive Action Plans
Designated School Employee and Agents
Immunity from Liability
Private Schools
Hawaii State Sources
| Type | Source |
|---|---|
| Summary | https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=SB&billnumber=1213&year=2023 |
| Text | https://www.capitol.hawaii.gov/sessions/session2023/bills/SB1213_.HTM |
